Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
What's inside Mexico's Popocatépetl? Scientists obtain first 3D images of the whole volcano - 2The Secret Destinations Amex Says Will Be More Popular Than Bali by 2026
- 3How did humans evolve, and will we evolve more?
- 4Pick Your #1 Kind Of Treat
- 5Selena Quintanilla documentary 'Selena y Los Dinos: A Family's Legacy' is coming to Netflix
- FACT FOCUS: Trump sows confusion on number of childhood vaccinations
- The Best 20 Tunes that Characterized an Age
- Gen Z workplace stereotypes were TV’s favorite punchline in 2025
- RFK Jr. succeeds in changing hepatitis B recommendation | The Excerpt
- 5 Signs Now is the ideal time to Update Your Android Telephone: When to Take the Action
- Hundreds show fascist salute at rally in Rome in annual ritual
- 5 Advancement Developments in Biotechnology
- Human evolution’s biggest mystery has started to unravel. How 2025 tipped the scales
- Telecommute Arrangement: What's Pivotal for Your Efficiency?
